Daniel Mink

USPTO Granted Patents = 11 (Patent Applications = 2)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 31(Granted Patents)

Location History:

Eupen, NL (2005)
Echt, NL (2015)
Eupen, BE (2003 - 2020)

Company Filing History:

Astra Zeneca U.k. Limited

patents

2 out of 68

Basilea Pharmaceutica Ag

patents

4. 1 out of 20

Dsm Sinochem Pharmaceuticals Netherlands B.v.

Years Active: 2003-2020

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10590092 - Process for the manufacture of isavuconazole or ravuconazole (2020-03-17),

2. 9783508 - Process for the manufacture of isavuconazole or ravuconazole (2017-10-10),

3. 9150562 - Process for the preparation of diol sulfones (2015-10-06),

4. 7989643 - Process for the preparation of 2-(6-substituted-1,3-dioxane-4-yl)acetic acid derivatives (2011-08-02),

5. 7732621 - Process for the preparation of enantiomerically enriched indoline-2-carboxylic acid (2010-06-08),

6. 7642363 - Process for the preparation of 2-(6-substituted-1,3-dioxane-4-YL) acetic acid derivatives (2010-01-05),

7. 7439046 - Process for the preparation of 2,4-dideoxyhexoses and 2,4,6-trideoxyhexoses (2008-10-21),

8. 7423162 - Process for the preparation of (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitrile and derivatives (2008-09-09),

9. 6964863 - Process for the preparation of 2,4-dideoxyhexoses and 2,4,6-trideoxyhexoses (2005-11-15),

10. 6870059 - Process for the preparation of 2-(6-substituted-1,-3-dioxane-4-yl)acetic acid derivatives (2005-03-22),

11. 6603043 - Process for the preparation of (schiff bases of) &agr;-alkyl-&agr;-amino acid amides (2003-08-05),

Title: **The Innovative Contributions of Daniel Mink**

Introduction

Daniel Mink, an esteemed inventor based in Eupen, Belgium, holds a remarkable portfolio of 11 patents. His work primarily revolves around the chemical sciences, specifically in the development of novel compounds and manufacturing processes that have significant implications in the pharmaceutical industry.

Latest Patents

One of Daniel's notable inventions is a process for the manufacture of isavuconazole and ravuconazole. This invention details a method that focuses on producing diastereomerically and enantiomerically enriched triazole compounds. The process involves a Reformatsky reaction between a ketone and a 2-halozincpropionate ester, followed by a critical resolution step, often utilizing enzymatic resolution with an esterase enzyme. His contributions in this area underline the advancements in the synthesis of important pharmaceutical compounds.

Career Highlights

Daniel has had a profound impact on the industry through his work with leading companies such as DSM IP Assets B.V. and AstraZeneca U.K. Limited. His role in these organizations has seen him at the forefront of innovation and development, driving initiatives that enhance pharmaceutical manufacturing processes and product efficacy.

Collaborations

Throughout his career, Daniel has collaborated with prominent professionals in the field, including Jacob Hermanus Mattheus Kooistra and Hubertus Josephus Marie Zeegers. These partnerships have enabled him to merge ideas and technologies, further amplifying the impact of his inventions.

Conclusion

Daniel Mink is a notable figure in the realm of innovation and invention, particularly within the pharmaceutical sector. His contributions through his patents reflect a dedication to improving chemical processes and advancing medicinal chemistry. As he continues his work, it is evident that his influence will persist in shaping the future of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.